Roanne Segal

Summary

Affiliation: University of Ottawa
Country: Canada

Publications

  1. pmc Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial
    Kerry S Courneya
    Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta, Canada
    Int J Behav Nutr Phys Act 5:52. 2008
  2. ncbi request reprint Surveillance programs for stage I nonseminomatous germ cell tumors of the testis
    Roanne Segal
    Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Urol Oncol 24:68-74. 2006
  3. doi request reprint Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer
    Roanne J Segal
    Ottawa Hospital Regional Cancer Center University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    J Clin Oncol 27:344-51. 2009
  4. ncbi request reprint Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome
    Shawn Malone
    Department of Radiation and Medical Oncology, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Int J Radiat Oncol Biol Phys 68:699-706. 2007
  5. ncbi request reprint A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach
    E Choan
    Division of Radiation Oncology, The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Urol Oncol 23:108-13. 2005
  6. ncbi request reprint Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres
    D Scott Ernst
    London Regional Cancer Centre, London, Ontario, Canada
    Can J Urol 12:2575-80. 2005
  7. ncbi request reprint Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study
    Shawn Malone
    Department of Radiation and Medical Oncology, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    BJU Int 96:514-20. 2005
  8. doi request reprint A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer
    Susan F Dent
    The Ottawa Hospital Regional Cancer Centre, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada
    Cancer Chemother Pharmacol 65:557-61. 2010
  9. ncbi request reprint Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline
    Roanne Segal
    Ottawa Regional Cancer Centre, Ontario, Canada
    Can J Urol 9:1625-33. 2002

Collaborators

Detail Information

Publications9

  1. pmc Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial
    Kerry S Courneya
    Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta, Canada
    Int J Behav Nutr Phys Act 5:52. 2008
    ..The purpose of the present study was to examine factors associated with breast cancer patients' preference for two types of exercise training during chemotherapy...
  2. ncbi request reprint Surveillance programs for stage I nonseminomatous germ cell tumors of the testis
    Roanne Segal
    Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Urol Oncol 24:68-74. 2006
    ..This article reviews the surveillance programs described in the literature to date with respect to both suitability and program design...
  3. doi request reprint Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer
    Roanne J Segal
    Ottawa Hospital Regional Cancer Center University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    J Clin Oncol 27:344-51. 2009
    ....
  4. ncbi request reprint Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome
    Shawn Malone
    Department of Radiation and Medical Oncology, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Int J Radiat Oncol Biol Phys 68:699-706. 2007
    ..To present the mature experience of a phase II trial of intermittent androgen suppression (IAS)...
  5. ncbi request reprint A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach
    E Choan
    Division of Radiation Oncology, The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Urol Oncol 23:108-13. 2005
    ..To evaluate the efficacy and toxicity of green tea, prescribed as an alternative complementary (CAM) formulation on hormone refractory prostate cancer (HRPC)...
  6. ncbi request reprint Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres
    D Scott Ernst
    London Regional Cancer Centre, London, Ontario, Canada
    Can J Urol 12:2575-80. 2005
    ..We evaluate the impact of surveillance programs on the outcome of men with clinical stage 1 NSGCT following orchidectomy...
  7. ncbi request reprint Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study
    Shawn Malone
    Department of Radiation and Medical Oncology, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    BJU Int 96:514-20. 2005
    ..To assess the feasibility and tolerability of intermittent androgen suppression therapy (IAS) in prostate cancer...
  8. doi request reprint A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer
    Susan F Dent
    The Ottawa Hospital Regional Cancer Centre, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada
    Cancer Chemother Pharmacol 65:557-61. 2010
    ..This phase II study was designed to assess the efficacy of Gemcitabine (GEM) and PEM given in a novel schedule in metastatic breast cancer (MBC) patients...
  9. ncbi request reprint Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline
    Roanne Segal
    Ottawa Regional Cancer Centre, Ontario, Canada
    Can J Urol 9:1625-33. 2002
    ..To examine the role of adjuvant chemotherapy in the treatment of patients with deep muscle-invasive transitional cell carcinoma (TCC) of the bladder who have undergone cystectomy...